COST 发表于 2025-3-30 12:10:16

Adalimumabmay elicit immune responses that potentially limit its long-term use in patients with chronic conditions such as rheumatoid arthritis, adalimumab is fully human, lowering the potential for immunogenicity (.).

咯咯笑 发表于 2025-3-30 13:24:33

http://reply.papertrans.cn/19/1876/187535/187535_52.png
页: 1 2 3 4 5 [6]
查看完整版本: Titlebook: Biologics in General Medicine; Wolf-Henning Boehncke,Heinfried H. Radeke Book 2007 Springer-Verlag Berlin Heidelberg 2007 Arthritis.Monito